Breyer Capital

Builds AI models trained on patient tissue and clinical data for disease diagnostics

Develops potent and durable mRNA medicines using the APEXm platform for autoimmune and oncology

Provides AI-powered medical search engine for clinicians

Uses cells as sensors to uncover first-in-class medicines